Presented by the Nurse Practitioner Healthcare Foundation, a member of the Collaborative on REMS Education (CO*RE), 10 interdisciplinary organizations working together to improve pain management and prevent adverse outcomes. The FDA is concerned about the continuing problem of severe adverse outcomes, including addiction, unintentional overdose, and death, of the inappropriate prescribing, misuse, and abuse of extended- release (ER) and long-acting (LA) opioids. There are mandated educational efforts and a list of competencies that all opioid prescribers should achieve: the FDA Blueprint. This workshop describes the CO*RE (Collaborative for REMS Education) Project, a group of 10 national organizations and several in-cooperation with organizations working together for the past 3 years to develop a comprehensive educational program that addresses this new FDA requirement for a risk evaluation and mitigation strategy (REMS) for opioid therapy.
Contact hours available until 9/21/2015.
Requirements for Successful Completion: Complete the learning activity in its entirety and complete the online CNE evaluation.
Conflict of Interest Disclosure: Speakers have no disclosures to declare.
Commercial Support and Sponsorship: No commercial support or sponsorship declared.
Accreditation Statement: This educational activity has been co-provided by Anthony J. Jannetti, Inc. and GAPNA.
Anthony J. Jannetti, Inc. is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
Anthony J. Jannetti, Inc. is a provider approved by the California Board of Registered Nursing, provider number, CEP 5387.
Describe appropriate patient assessment for treatment with ER/LA opioid analgesics.
Describe “best practices” for prescribing of ER/LA opioid analgesics.
Demonstrate accurate knowledge about how to manage ongoing therapy with ER/LA opioid analgesics.
Describe the methods to counsel patients and caregivers about the safe use of ER/LA opioid analgesics.